The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for Delivra Health Brands's 9-Day RSI or its related term are showing as below:
STU:3F0's 9-Day RSI is ranked worse than 61.6% of 1047
companies
in the Drug Manufacturers industry
Industry Median: 54.44
vs STU:3F0: 38.62
Delivra Health Brands (STU:3F0) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Delivra Health Brands 9-Day RSI Related Terms
STU:3F0 vs ZTS, UTHR: 9-Day RSI Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delivra Health Brands 9-Day RSI vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Delivra Health Brands's 9-Day RSI falls into.
Delivra Health Brands (STU:3F0) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delivra Health Brands (STU:3F0) has a 9-Day RSI of 38.62 as of Jul. 08, 2026. According to the industry distribution chart, Delivra Health Brands ranks #645 out of 1047 companies in the Drug Manufacturers industry, placing it in the top 61.6%.
Is Delivra Health Brands' 9-Day RSI too high?
Delivra Health Brands' current 9-Day RSI is 38.62. The Drug Manufacturers industry median 9-Day RSI is 54.44. Delivra Health Brands' value of 38.62 is 29.1% below this industry median. Based on the distribution chart, Delivra Health Brands ranks #645 out of 1047 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Delivra Health Brands has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Delivra Health Brands' 9-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #645 out of 1047 companies for 9-Day RSI. This places Delivra Health Brands in the lower half of its industry. The industry median 9-Day RSI is 54.44. Delivra Health Brands' value of 38.62 is 29.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Drug Manufacturers company?
The median 9-Day RSI among Drug Manufacturers companies is 54.44, based on 1,047 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delivra Health Brands's current 9-Day RSI of 38.62 is 29.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 9-Day RSI is 54.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delivra Health Brands's current 9-Day RSI is 38.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Delivra Health Brands (STU:3F0) has a current 9-Day RSI of 38.62. The stock's GF Value™ is €0.12, compared to a current price of €0.05 — trading 55.4% below its estimated fair value. The current 9-Day RSI is 38.62 and 29.1% below the Drug Manufacturers industry median of 54.44. Delivra Health Brands' overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Delivra Health Brands (STU:3F0), the current 9-Day RSI is 38.62 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Delivra Health Brands (STU:3F0) Overvalued in 2026?
Based on GuruFocus' analysis, Delivra Health Brands stock appears to be undervalued.
The current stock price of €0.05 is trading 55.4% below its estimated GF Value™ of €0.12.
Key valuation signals for STU:3F0:
9-Day RSI: 38.62
GF Value™: €0.12 vs. price of €0.05 (55.4% below fair value)
Industry Position: 29.1% below the Drug Manufacturers median (#645 of 1047)
No single metric tells the full story. See the STU:3F0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.
28GF Score
Get the complete analysis for STU:3F0
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:3F0 has been successfully added to your 